$328.55
▲ +0.1% Today
as of Sep 4, 16:52 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 3
● 22
▼ 0
Natera & Angiex Partner to Evaluate AGX101 Response With Signatera
Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
How Investors May Respond To Natera (NTRA) New MRD Trial Deal And Duquesne Stake Expansion
Overview
52-week range
$157
$343
92% of range
Avg surprise (last 3)
-4.6%
Avg reaction (last 2)
+1.9%
100% positive
Latest IV / EM
43%
EM ±6.6% · $330 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.47 | — | — | — | — | financials |
| Thu May 7, 2026 | Mar/2026 | $-0.56 | $-0.53 | -5.7% | -12.0% | +2.2% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.64 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.74 | $-0.60 | -23.3% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.50 | $-0.59 | +15.2% | — | +1.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.26 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.30 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.56 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.95 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.97 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.23 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $753M | $697M | — | $592M | $547M | $502M | — | $440M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-76M | $-94M | — | $-98M | $-110M | $-79M | — | $-39M |
| Net income | $-67M | $-85M | — | $-88M | $-101M | $-67M | — | $-32M |
| EPS (diluted) | $-0.47 | $-0.60 | — | $-0.64 | $-0.74 | $-0.50 | — | $-0.26 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Inventory | $80M | $71M | $68M | $65M | $54M | $50M | $45M | $49M |
| Total current assets | $1.66B | $1.65B | $1.50B | $1.45B | $1.43B | $1.42B | $1.38B | $1.32B |
| Total assets | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $836M | $840M | $686M | $569M | $511M | $493M | $465M | $712M |
| Total equity | $1.82B | $1.77B | $1.71B | $1.25B | $1.25B | $1.24B | $1.20B | $879M |